SignatureFD’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.37K | Hold |
141
| – | – | ﹤0.01% | 2706 |
|
2025
Q1 | $3.5K | Hold |
141
| – | – | ﹤0.01% | 2703 |
|
2024
Q4 | $2.66K | Buy |
141
+56
| +66% | +$1.06K | ﹤0.01% | 2775 |
|
2024
Q3 | $1.28K | Sell |
85
-12
| -12% | -$181 | ﹤0.01% | 2940 |
|
2024
Q2 | $2.78K | Sell |
97
-257
| -73% | -$7.35K | ﹤0.01% | 2667 |
|
2024
Q1 | $10.3K | Buy |
354
+7
| +2% | +$205 | ﹤0.01% | 2281 |
|
2023
Q4 | $11.7K | Buy |
347
+313
| +921% | +$10.6K | ﹤0.01% | 2185 |
|
2023
Q3 | $1.04K | Sell |
34
-20
| -37% | -$614 | ﹤0.01% | 2923 |
|
2023
Q2 | $2.16K | Sell |
54
-450
| -89% | -$18K | ﹤0.01% | 2776 |
|
2023
Q1 | $20.6K | Buy |
504
+439
| +675% | +$17.9K | ﹤0.01% | 1857 |
|
2022
Q4 | $2.51K | Sell |
65
-17
| -21% | -$656 | ﹤0.01% | 2725 |
|
2022
Q3 | $4K | Buy |
82
+18
| +28% | +$878 | ﹤0.01% | 2542 |
|
2022
Q2 | $4K | Buy |
64
+33
| +106% | +$2.06K | ﹤0.01% | 2528 |
|
2022
Q1 | $2K | Hold |
31
| – | – | ﹤0.01% | 2829 |
|
2021
Q4 | $2K | Hold |
31
| – | – | ﹤0.01% | 2765 |
|
2021
Q3 | $2K | Hold |
31
| – | – | ﹤0.01% | 2682 |
|
2021
Q2 | $2K | Hold |
31
| – | – | ﹤0.01% | 2596 |
|
2021
Q1 | $2K | Hold |
31
| – | – | ﹤0.01% | 2502 |
|
2020
Q4 | $2K | Sell |
31
-8
| -21% | -$516 | ﹤0.01% | 2285 |
|
2020
Q3 | $2K | Buy |
39
+8
| +26% | +$410 | ﹤0.01% | 2247 |
|
2020
Q2 | $2K | Buy |
+31
| New | +$2K | ﹤0.01% | 2153 |
|